Diabetes Self-management Education Program for Medicaid Recipients

Abstract

Purpose

Diabetes self-management education (DSME) is the cornerstone in effective management of diabetes. The continuous quality improvement process was used to identify the problem, collect and analyze data, and develop and implement a DSME program for Medicaid recipients, and subsequently, the program was evaluated to assess its effectiveness.

Methods

A DSME program consisting of a 1-hour initial assessment of individual needs followed by 12 hours of group education on nutrition and self-management was provided to 212 Arkansas Medicaid recipients over 1 year. Key clinical measures were assessed at the end of the period.

Results

Over 1 year, mean HbA1c declined by 0.45% among the DSME participants who completed the full program. Multivariate analyses found that after controlling for age, gender, race, preperiod diabetes drug use, and preperiod costs, DSME participants were found to have fewer hospital admissions, emergency department visits, and outpatient visits. Changes from baseline clinical values for DSME participants were used to project changes in diabetes-related costs using the Gilmer model. An estimated savings in diabetes-related cost over 3 years was $415 per program completer. Over 10 years, completers were estimated to experience 12% fewer coronary heart disease events and 15% fewer microvascular disease events using the United Kingdom Prospective Diabetes Study risk models.

Conclusions

A DSME program for Medicaid recipients can reduce health care use among Medicaid recipients with diabetes within 1 year and over longer periods of time is likely to reduce costs associated with reduced use of health care. Plans are in place to explore the possibility of sustaining the program.

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention

. Guide to community preventive services: diabetes. Available at http://www.thecommunityguide.org/diabetes/default.htm. Accessed April 14, 2005.

Engelgau MM

Geiss LS

Saaddine JB

et al.

The evolving diabetes burden in the United States. Ann Intern Med. 2004;140 (suppl): 945-950.

Hogan P

Dall T

Nikolov P.

Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26: 917-932.

Ettaro L

Songer TJ

Zhang P

Engalgau MM.

Cost-of illness studies in diabetes mellitus. Pharmacoeconomics. 2004;22: 149-164.

Klonoff DC

Schwartz DM.

An economic analysis of interventions for diabetes. Diabetes Care. 2000;23: 390-404.

Zhang P

Engelgau M

Norris S

Gregg E

Narayan KMV.

Application of economic analysis to diabetes and diabetes care. Ann Intern Med. 2004;140(suppl): 972-977.

American Association of Diabetes Educators

. CQI: A Step-by-Step Guide for Quality Improvement in Diabetes Education. Chicago, Ill: American Association of Diabetes Educators; 2005.

National Diabetes Surveillance System

. Data & trends. Available at: http://www.cdc.gov/diabetes/statistics/preventive/tY.htm. Accessed May 31, 2005.

American Association of Diabetes Educators

. The Guide to Reimbursement. Chicago, Ill: American Association of Diabetes Educators; 2003.

10.

Pearson J

Mensing C

Anderson R.

Medicare reimbursement and diabetes self-management training: national survey results. Diabetes Educ. 2004;30: 914-927.

11.

Balanced Budget Act of 1997, §4105 (1998).

12.

Funnell MM

Hunt C

Kulkarni K

Rubin RR

Yarborough PC

, eds. A Core Curriculum for Diabetes Education. 3rd ed. Chicago, Ill: American Association of Diabetes Educators; 1998.

13.

Norris SL

Engelgau M

Narayan KMV.

Effectiveness of self-management training in type 2 diabetes. Diabetes Care. 2001;24: 561-587.

14.

International Classification of Diseases codes [Centers for Disease Control and Prevention Web site]. Available at: http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm. Accessed June 7, 2005.

15.

Current Procedural Terminology codes [American Medical Association Web site]. Available at: http://www.ama-assn.org/ama/pub/category/3113.html. Accessed June 7, 2005.

16.

Iennoni LI

, ed. Risk Adjustment for Measuring Healthcare Outcomes. 2nd ed. Chicago, Ill: Health Administration Press; 1997.

17.

Gilmer TP

O’Connor PJ

Manning WG

Rush WA.

The cost to health plans of poor glycemic control. Diabetes Care. 1997;20: 1847-1853.

18.

United Kingdom Prospective Diabetes Study Group

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risks of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352: 837-853.

19.

Stratton IM

Adler AI

Andrew H

et al.

Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321: 405-412.

20.

Stevens RJ

Kothari V

Adler AI

et al.

The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci. 2001;101: 671-679.

21.

Kothari V

Stevens RJ

Adler AI

et al.

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK prospective diabetes study risk engine. Stroke. 2002;33: 1776-1781.

22.

Saydah SH

Fradkin J

Cowie CC.

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291: 335-342.

23.

Balamurugan A.

The state of diabetes in Arkansas. Available at: http://www.healthyarkansas.com/services/pdf/diabetes_in_arkansas.pdf. Accessed June 7, 2003.

24.

Weintraub WS

Craver JM

Jones EL

et al.

Improving cost and outcome of coronary surgery. Circulation. 1998:98(suppl 1): II23-II28.

25.

Sarasin FP

Gaspoz J-M

Bounameaux H.

Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack. Arch Intern Med. 2000;160: 2773-2778.